Cat. No.
1015-02

Size
1.0 mg

Price (USD)
$80.00

Qty	Add to Cart

Technical Bulletin Certificate of
Analysis Safety Data Sheet Bulk/Custom
Quotation Request Email Technical
Service

Specificity	Reacts with the Fab region of mouse IgG₁, IgG_2a, IgG_2b, IgG_2c, and IgG₃
Source	Pooled antisera from goat hyperimmunized with mouse IgG
Cross Adsorption	Mouse IgG Fc; may react with immunoglobulins from other species and the light chains of other mouse immunoglobulins
Purification	Affinity chromatography on mouse IgG Fab covalently linked to agarose
Isotype	Goat IgG
Isotype Control	Goat IgG-FITC
Format/Conjugate	FITC (Fluorescein)
Buffer Formulation	Phosphate buffered saline containing 0.1% sodium azide
Concentration	1.0 mg/mL
Volume	1.0 mL
Storage & Handling	2-8°C; Avoid exposure to light Please refer to product specific SDS
Applications	Quality tested applications for relevant formats include - ELISA ^1-4 FLISA
Recommended Dilutions	Please refer to product specific Technical Bulletin

FLISA plate was coated with purified mouse IgG Fab and IgG Fc. Immunoglobulins were detected with serially diluted Goat Anti-Mouse IgG Fab-FITC (SB Cat. No. 1015-02).

FLISA plate was coated with purified mouse IgG Fab and IgG Fc. Immunoglobulins were detected with serially diluted Goat Anti-Mouse IgG Fab-FITC (SB Cat. No. 1015-02).

References

1.	Beck Z, Matyas GR, Jalah R, Rao M, Polonis VR, Alving CR. Differential immune responses to HIV-1 envelope protein induced by liposomal adjuvant formulations containing monophosphoryl lipid A with or without QS21. Vaccine. 2015;33:5578-87. (ELISA)
2.	Alving CR, Beck Z, inventors; The Government of the United states of America as Represented by the Secretary of the Army, assignee. Non-toxic adjuvant formulation comprising a monophosphoryl lipid A (MPLA)-containing liposome composition and a saponin. United States patent application publication US 2017/0182152 A1. 2017 Jun 29. (ELISA)
3.	Beck Z, Torres OB, Matyas GR, Lanar DE, Alving CR. Immune response to antigen adsorbed to aluminum hydroxide particles: Effects of co-adsorption of ALF or ALFQ adjuvant to the aluminum-antigen complex. J Control Release. 2018;275:12-19. (ELISA)
4.	Lee J, Park E, Min J, Sung S, Jang Y, Shin JS, et al. Systematic editing of synthetic RIG-I ligands to produce effective antiviral and anti-tumor RNA immunotherapies. Nucleic Acids Res. 2018;46:1635-47. (ELISA)

Back to Product List